Coronation Fund Managers Ltd. Buys Shares of 10,031 Humana Inc. $HUM

Key Points

• Coronation Fund Managers bought a new stake of 10,031 shares of Humana in Q4, valued at about $2.57 million, signaling notable institutional buying activity.
• Insider Sanjay K. Shetty purchased 810 shares at $185.21 on Feb. 23, raising his holdings to 11,657 shares, a 7.47% increase in his ownership.
• Analysts are mixed: the consensus rating is Hold with a consensus target of $222.09, after several firms adjusted price targets and ratings (including Evercore raising its target and others cutting theirs).

Coronation Fund Managers Ltd. bought a new stake in Humana Inc. (NYSE:HUM - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 10,031 shares of the insurance provider's stock, valued at approximately $2,569,000.

Other hedge funds also recently added to or reduced their stakes in the company. Sound View Wealth Advisors Group LLC grew its position in shares of Humana by 3.5% in the fourth quarter. Sound View Wealth Advisors Group LLC now owns 1,060 shares of the insurance provider's stock valued at $272,000 after purchasing an additional 36 shares during the last quarter. Unison Advisors LLC grew its position in shares of Humana by 0.4% in the third quarter. Unison Advisors LLC now owns 10,137 shares of the insurance provider's stock valued at $2,646,000 after purchasing an additional 37 shares during the last quarter. CoreCap Advisors LLC grew its position in shares of Humana by 54.4% in the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider's stock valued at $27,000 after purchasing an additional 37 shares during the last quarter. Insigneo Advisory Services LLC grew its position in shares of Humana by 3.0% in the third quarter. Insigneo Advisory Services LLC now owns 1,484 shares of the insurance provider's stock valued at $386,000 after purchasing an additional 43 shares during the last quarter. Finally, Columbus Macro LLC grew its position in shares of Humana by 5.5% in the fourth quarter. Columbus Macro LLC now owns 821 shares of the insurance provider's stock valued at $210,000 after purchasing an additional 43 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Humana

In other news, insider Sanjay K. Shetty bought 810 shares of the firm's stock in a transaction that occurred on Monday, February 23rd. The shares were purchased at an average price of $185.21 per share, for a total transaction of $150,020.10. Following the completion of the transaction, the insider owned 11,657 shares in the company, valued at $2,158,992.97. The trade was a 7.47% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.20% of the company's stock.

Analysts Set New Price Targets

Several research firms have recently commented on HUM. Evercore increased their price target on shares of Humana from $180.00 to $195.00 in a research report on Wednesday, April 8th. UBS Group reiterated a "neutral" rating on shares of Humana in a research report on Wednesday, February 25th. Leerink Partners lowered their price target on shares of Humana from $267.00 to $185.00 and set a "market perform" rating on the stock in a research report on Thursday, February 12th. Wolfe Research lowered their price target on shares of Humana from $325.00 to $250.00 and set an "outperform" rating on the stock in a research report on Monday, April 6th. Finally, Zacks Research lowered shares of Humana from a "hold" rating to a "strong sell" rating in a research report on Tuesday, April 14th. Seven analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and four have given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $222.09.

Humana Stock Up 0.1%

Shares of NYSE HUM opened at $215.26 on Friday. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $315.35. The firm's 50 day moving average price is $184.64 and its 200 day moving average price is $229.11. The firm has a market cap of $25.84 billion, a P/E ratio of 21.92, a price-to-earnings-growth ratio of 2.30 and a beta of 0.44. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.00 and a current ratio of 2.00.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($4.01) by $0.05. Humana had a net margin of 0.92% and a return on equity of 11.43%. The firm had revenue of $32.64 billion for the quarter, compared to analyst estimates of $32.08 billion. During the same quarter last year, the business earned ($2.16) earnings per share. Humana's revenue was up 11.3% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. As a group, sell-side analysts anticipate that Humana Inc. will post 9.05 earnings per share for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.6%. Humana's dividend payout ratio (DPR) is 36.05%.

About Humana

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.